Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma
U. Popat, C. Hosing, R. M. Saliba, P. Anderlini, K. van Besien, D. Przepiorka, I. F. Khouri, J. Gajewski, D. Claxton, S. Giralt, M. Rodriguez, J. Romaguera, F. Hagemeister, C. Ha, J. Cox, F. Cabanillas, B. S. Andersson, R. E. Champlin
Dive into the research topics of 'Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma'. Together they form a unique fingerprint.